PortfoliosLab logoPortfoliosLab logo

ProShares UltraShort Nasdaq Biotechnology (BIS) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BIS. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to BIS

BIS charges 0.95% annually. There are 100 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.


Best Risk-Adjusted Alternatives to BIS

BIS has a PortfoliosLab risk / return rank of 1. There are 265 ETFs in the Leveraged Equities category with higher risk-adjusted ranks, going as high as 99.


Top Performing BIS Alternatives (YTD)

BIS is at -27.05% YTD. There are 244 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 738.32%.


Lowest Volatility Alternatives to BIS

BIS has 41.05% 1-year volatility. There are 84 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.77%.


Lowest Drawdown Alternatives to BIS

BIS has a 1-year max drawdown of -60.93%. There are 178 ETFs in the Leveraged Equities category with shallower 1-year drawdowns, going as shallow as -1.72%.


Other ETFs from ProShares

The 10 most viewed ProShares ETFs shown here include TQQQ, QLD, BITO and span 10 categories. AUM among these funds goes as high as $37B.


Often Compared With BIS

Investors most often compare BIS with BIB, RSPN, IBBQ. These 20 comparison targets span 10 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
ProShares Ultra Nasdaq BiotechnologyLeveraged Equities
88
25.21%
86.42MApr 2010BIS vs BIB
Invesco S&P 500® Equal Weight Industrials ETFIndustrials Equities, S&P 500, Equal Weight
33
11.53%
1.09BJan 2006BIS vs RSPN
Invesco Nasdaq Biotechnology ETFHealth & Biotech Equities
91
15.12%
74.65MJun 2021BIS vs IBBQ
AdvisorShares Ranger Equity Bear ETFInverse Equities
9
-0.94%
64.16MJan 2011BIS vs HDGE
Innovator IBD 50 ETFLarge Cap Growth Equities
26
12.47%
89.40MApr 2015BIS vs FFTY
State Street Health Care Select Sector SPDR ETFHealth & Biotech Equities
49
5.16%
41.65BDec 1998BIS vs XLV
Nasdaq, Inc.
44
-7.53%
BIS vs NDAQ
Invesco Dynamic Pharmaceuticals ETFHealth & Biotech Equities
91
13.12%
357.90MJun 2005BIS vs PJP
Global X DAX Germany ETFEurope Equities
9
-1.27%
239.74MOct 2014BIS vs DAX
Leverage Shares 2X Long CMG Daily ETFLeveraged Equities
-14.15%
1.52MNov 2025BIS vs CMGG
Vanguard Information Technology ETFTechnology Equities
57
22.94%
170.10BMar 2004BIS vs VGT
GraniteShares 2x Long VRT Daily ETFLeveraged Equities
81
157.20%
59.39MMar 2025BIS vs VRTL
Leverage Shares 2X Long PYPL Daily ETFLeveraged Equities
3
-44.39%
18.66MApr 2025BIS vs PYPG
Leverage Shares 2X Long XYZ Daily ETFLeveraged Equities
12
18.38%
2.77MApr 2025BIS vs XYZG
Leverage Shares 2X Long COST Daily ETFLeveraged Equities
6.96%
7.99MSep 2025BIS vs COTG
Direxion Daily GOOGL Bull 2X SharesLeveraged Equities
94
15.18%
1.10BSep 2022BIS vs GGLL
Leverage Shares 2X Long TSM Daily ETFLeveraged Equities
78
64.79%
32.98MJan 2025BIS vs TSMG
Direxion Daily Semiconductor Bull 3X ETFLeveraged Equities, Semiconductors
93
293.46%
25.32BMar 2010BIS vs SOXL
SPDR S&P Biotech ETFHealth & Biotech Equities
94
27.53%
11.10BFeb 2006BIS vs XBI
Leverage Shares 2X Long ARM Daily ETFLeveraged Equities
41
374.91%
101.28MJan 2025BIS vs ARMG

Compare BIS with Any Fund or Stock

Compare BIS with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair BIS with funds that move differently

ProShares UltraShort Nasdaq Biotechnology alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BIS.

Explore BIS Diversifiers